Hormone replacement therapy and reduced cognitive decline in older women - The Cache County Study

被引:89
作者
Carlson, MC
Zandi, PP
Plassman, BL
Tschanz, JT
Welsh-Bohmer, KA
Steffens, DC
Bastian, LA
Mehta, KM
Breitner, JCS
机构
[1] Johns Hopkins Univ, Ctr Aging & Hlth, Dept Mental Hyg, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD 21205 USA
[3] Utah State Univ, Dept Psychol, Logan, UT 84322 USA
[4] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA
[5] Duke Univ, Med Ctr, Dept Internal Med, Durham, NC 27710 USA
[6] Duke Univ, Med Ctr, Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC 27710 USA
[7] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA
关键词
D O I
10.1212/WNL.57.12.2210
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To examine the association between postmenopausal hormone replacement therapy (HRT) and the trajectory of global cognitive change with age. Methods: The Modified Mini-Mental State Examination (MMSE) was administered to a population sample of 2,073 nondemented, community-dwelling female residents of Cache County, UT, aged 65 and older. Current and past HRT and other medications at a baseline interview and at follow-up 3 years later were assessed. Between interviews, a telephone Women's Health Questionnaire was administered to assess initial exposure, duration, and recency of HRT. Generalized estimating equation marginal models were used to evaluate the cross-sectional and longitudinal relations of HRT and modified MMSE score. Also assessed were effects with multivitamins and calcium supplements as exposures likely to reflect a "healthy lifestyle" among HRT users. Model covariates included the presence of APOE epsilon4 alleles, age, education, concurrent depression, several chronic diseases, and self-perceived general health. Results: Age, lower education, depression, and APOE epsilon4 were all associated with lower baseline modified MMSE scores. With these covariates in the model, lifetime HRT use was associated with better baseline modified MMSE scores and a slower rate of decline. Stratification by APOE genotype did not alter these effects. Apparent benefits with HRT were attenuated but remained significant after elimination of scores from participants with incident dementia. A significant interaction between age and HRT indicated the strongest effects in women aged 85 and older. Measures of age at initial use of HRT, duration, and recency of exposure did not improve the models. No effects were seen with the "healthy lifestyle" control exposures. Conclusions: In a population cohort of older women, lifetime FIRT exposure was associated with improved global cognition and attenuated decline over a 3-year interval. Improvements were greatest in the oldest old.
引用
收藏
页码:2210 / 2216
页数:7
相关论文
共 50 条
  • [21] Hormone replacement therapy and stroke risk in older women.
    Fung, MM
    Barrett-Connor, EL
    Bettencourt, RR
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 81A - 81A
  • [22] Hormone replacement therapy and longitudinal cognitive performance in postmenopausal women
    O'Hara, R
    Schröder, CM
    Bloss, C
    Bailey, AM
    Alyeshmerni, AM
    Mumenthaler, MS
    Friedman, LF
    Yesavage, JA
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 13 (12) : 1107 - 1110
  • [23] Effects of hormone replacement therapy on cognitive performance in elderly women
    Binder, EF
    Schechtman, KB
    Birge, SJ
    Williams, DB
    Kohrt, WM
    MATURITAS, 2001, 38 (02) : 137 - 146
  • [24] Hormone replacement therapy to maintain cognitive function in women with dementia
    Hogervorst, Eva
    Yaffe, Kristine
    Richards, Marcus
    Huppert, Felicia A. H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):
  • [25] DASH DIET ADHERENCE SCORES AND COGNITIVE DECLINE AMONG AGING MEN AND WOMEN: CACHE COUNTY STUDY OF MEMORY HEALTH AND AGING
    Wengreen, H.
    Nelson, C.
    Munger, R.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 : S88 - S88
  • [26] Electrophysiological neuroimaging of age-related cognitive decline and hormone replacement therapy
    Saletu, B
    Anderer, P
    Gruber, D
    Metka, M
    Huber, J
    Saletu-Zyhlarz, GM
    MENOPAUSE: STATE OF THE ART - IN RESEARCH AND MANAGEMENT, 2003, : 201 - 210
  • [27] Hormone replacement therapy and cognitive performance in postmenopausal women - a review by cognitive domain
    Low, LF
    Anstey, KJ
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2006, 30 (01) : 66 - 84
  • [28] Postmenopausal hormone therapy and risk of cognitive decline in aging women.
    Kang, JH
    Weuve, J
    Grodstein, F
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (11) : S2 - S2
  • [29] STRESSFUL EVENTS IN LATE-LIFE: EFFECTS ON COGNITIVE DECLINE. THE CACHE COUNTY STUDY
    Tschanz, J.
    Pfister, R.
    Steffens, D. C.
    Corcoran, C.
    Smith, K.
    Ostbye, T.
    Welsh-Bohmer, K.
    Norton, M. C.
    GERONTOLOGIST, 2010, 50 : 354 - 354
  • [30] Antioxidant intake and cognitive function of elderly men and women: The cache county study
    Wengreen, H. J.
    Munger, R. G.
    Corcoran, C. D.
    Zandi, P.
    Hayden, K. M.
    Fotuhi, M.
    Skoog, I.
    Norton, M. C.
    Tschanz, J.
    Breitner, J. C. S.
    Welsh-Bohmer, K. A.
    JOURNAL OF NUTRITION HEALTH & AGING, 2007, 11 (03) : 230 - 237